Iofina posts record 2025 results, boosts output outlook with Permian expansion

About this episode

Iofina's CEO discusses the company's record financial results and future expansion plans.

Iofina Plc. CEO Thomas Becker joined Steve Darling from Proactive to discuss the company’s latest financial performance, highlighting a series of record-breaking results in its audited full-year report for the period ending December 2025. Becker outlined that the company delivered another standout year, reporting revenue of $66.5 million—an increase of 22% year-over-year—marking its eighth consecutive year of sustained growth. He attributed much of this momentum to strong operational performance across its core iodine business, with crystalline iodine sales surging by 42%, while iodine derivatives sales posted a solid 5% increase. This top-line growth translated into significant profitability gains. Gross profit rose 36% to $18.0 million, supported by improved efficiencies and favourable pricing. Adjusted EBITDA saw an even sharper rise of 56%, reflecting strong operational leverage, while operating profit climbed 74%. Profit before tax reached $8.4 million, representing a 75% increase compared to the previous year, underscoring the company’s ability to convert revenue growth into bottom-line performance. Looking ahead, Becker emphasized Iofina’s strategic focus on scaling its…

People in this episode

Host: Steve Darling

Guest: Thomas Becker

Topics covered

• financial performance
• iodine business
• operational efficiency
• growth strategy
• Permian expansion

Keywords

• Iofina
• financial results
• iodine sales
• Permian expansion
• operational performance
• EBITDA
• profit growth

Mentioned in this episode

Organizations: Iofina Plc.

Places: Permian Basin

More episodes of Proactive - Interviews for investors

• Regan Capital CIO on bond market opportunities in a rising rate environment · June 12, 2026 · 6 min
• Light Science Technologies lifts capacity 50% with new SMT line and global client win · June 12, 2026 · 5 min
• Poolbeg Pharma launches POLB 001 TOPICAL trial to tackle CAR-T side effects · June 12, 2026 · 4 min
• Lumos Diagnostics expands FebriDx adoption across 100+ US healthcare sites with CLIA Waiver · June 11, 2026 · 8 min
• Flow Metals advances drill-ready Yukon gold project while expanding Copper exploration in B.C. · June 11, 2026 · 6 min
• Midstream energy sector positioned for growth as LNG and AI drive demand · June 11, 2026 · 7 min